KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Encompass Health (EHC) Gains from Investment Securities (2016 - 2025)

Encompass Health (EHC) has disclosed Gains from Investment Securities for 17 consecutive years, with $9.9 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Gains from Investment Securities rose 607.14% year-over-year to $9.9 million, compared with a TTM value of $46.1 million through Sep 2025, up 4290.91%, and an annual FY2024 reading of $21.8 million, up 165.85% over the prior year.
  • Gains from Investment Securities was $9.9 million for Q3 2025 at Encompass Health, down from $28.8 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $30.0 million in Q2 2021 and bottomed at -$20.3 million in Q4 2022.
  • Average Gains from Investment Securities over 5 years is $3.2 million, with a median of $4.4 million recorded in 2024.
  • The sharpest move saw Gains from Investment Securities surged 738.3% in 2021, then crashed 1368.75% in 2022.
  • Year by year, Gains from Investment Securities stood at $1.6 million in 2021, then plummeted by 1368.75% to -$20.3 million in 2022, then skyrocketed by 34.98% to -$13.2 million in 2023, then skyrocketed by 173.48% to $9.7 million in 2024, then increased by 2.06% to $9.9 million in 2025.
  • Business Quant data shows Gains from Investment Securities for EHC at $9.9 million in Q3 2025, $28.8 million in Q2 2025, and -$2.3 million in Q1 2025.